{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:43:55Z","timestamp":1791150235871,"version":"4.1.0"},"reference-count":29,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and objectives: Bronchoalveolar lavage (BAL) is commonly performed to evaluate diffuse lung disease and occasionally to identify alveolar hemorrhage. However, the clinical impact of alveolar hemorrhage and its risk factors in patients with diffuse lung disease have not been clarified. Materials and Methods: We retrospectively analyzed the medical records of all patients who underwent BAL to evaluate diffuse lung disease from January 2017 to December 2020. Alveolar hemorrhage was defined as progressive hemorrhagic BAL fluid or the presence of \u226520% hemosiderin-laden macrophages in the BAL fluid. Logistic regression analysis was performed to assess the association between alveolar hemorrhage and other factors. Results: Sixty subjects were enrolled in this study. Alveolar hemorrhage was observed in 19 subjects (31.7%) with idiopathic interstitial pneumonia, acute respiratory distress syndrome, interstitial pneumonia with autoimmune features, drug-induced lung injury, eosinophilic pneumonia, adenocarcinoma, and systemic lupus erythematosus. The use of anticoagulants was a significant risk factor for alveolar hemorrhage (odds ratio 7.57, p = 0.049). Patients with alveolar hemorrhage required intubated mechanical ventilation more frequently (63.2% vs. 24.4%, p = 0.005) and had higher in-hospital mortality rates (26.3% vs. 4.9%, p = 0.028) than those without alveolar hemorrhage. Conclusions: Alveolar hemorrhage was observed in various etiologies. The use of anticoagulants was a significant risk factor for alveolar hemorrhage. Patients with alveolar hemorrhage showed more severe respiratory failure and had higher in-hospital mortality than those without alveolar hemorrhage.<\/jats:p>","DOI":"10.3390\/medicina57101094","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T21:48:39Z","timestamp":1634161719000},"page":"1094","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Anticoagulant Use as an Independent Risk Factor and Higher In-Hospital Mortality in Patients Showing Alveolar Hemorrhage in Diffuse Lung Disease"],"prefix":"10.3390","volume":"57","author":[{"given":"Motoi","family":"Ugajin","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Nagoya Tokushukai General Hospital, 2-52 Kouzouji-cho Kita, Kasugai City 487-0016, Japan"},{"name":"Department of Respiratory Medicine and Allergology, Aichi Medical University Hospital, Nagakute City 480-1195, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanori","family":"Kani","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Nagoya Tokushukai General Hospital, Kasugai City 487-0016, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nagoya Tokushukai General Hospital, Kasugai City 487-0016, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1183\/09059180.00005510","article-title":"The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease","volume":"19","author":"Wells","year":"2010","journal-title":"Eur. Respir. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","article-title":"An official American Thoracic Society clinical practice guideline: The clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease","volume":"185","author":"Meyer","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1164\/ajrccm.151.1.7812547","article-title":"Alveolar hemorrhage. Diagnostic criteria and results in 194 immunocompromised hosts","volume":"151","author":"Escudier","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1378\/chest.08-2084","article-title":"Diffuse alveolar hemorrhage","volume":"137","author":"Lara","year":"2010","journal-title":"Chest"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1253\/circj.69.216","article-title":"Risk of alveolar hemorrhage in patients with primary pulmonary hypertension--anticoagulation and epoprostenol therapy","volume":"69","author":"Ogawa","year":"2005","journal-title":"Circ. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1177\/0961203320920715","article-title":"Systemic lupus erythematosus-associated diffuse alveolar hemorrhage: A single-center, matched case-control study in China","volume":"29","author":"Sun","year":"2020","journal-title":"Lupus"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1148\/rg.273065051","article-title":"Eosinophilic lung diseases: A clinical, radiologic, and pathologic overview","volume":"27","author":"Jeong","year":"2007","journal-title":"Radiographics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European Respiratory Society\/American Thoracic Society research statement: Interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur. Respirat. J."},{"key":"ref_9","first-page":"2526","article-title":"ARDS Definition Task Force: Acute respiratory distress syndrome: The Berlin Definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1513\/pats.201101-007MW","article-title":"Pulmonary microcirculation in interstitial lung disease","volume":"8","author":"Farkas","year":"2011","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pupt.2013.12.002","article-title":"Iron laden macrophages in idiopathic pulmonary fibrosis: The telltale of occult alveolar hemorrhage?","volume":"28","author":"Puxeddu","year":"2014","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.smj.0000208971.43461.bb","article-title":"Amiodarone-induced alveolar hemorrhage","volume":"99","author":"Iskandar","year":"2006","journal-title":"South Med. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2169\/internalmedicine.50.4482","article-title":"Pneumocystis jirovecii pneumonia and alveolar hemorrhage in a pregnant woman with human T cell lymphotropic virus type-1 infection","volume":"50","author":"Tamaki","year":"2011","journal-title":"Intern. Med."},{"key":"ref_14","first-page":"623","article-title":"Novel H1N1 influenza A viral infection complicated by alveolar hemorrhage","volume":"55","author":"Gilbert","year":"2010","journal-title":"Respir. Care."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1183\/09031936.00119108","article-title":"Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage","volume":"33","author":"Maldonado","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13613-019-0540-9","article-title":"Formal guidelines: Management of acute respiratory distress syndrome","volume":"9","author":"Papazian","year":"2019","journal-title":"Ann. Intensive Care"},{"key":"ref_17","first-page":"7938062","article-title":"Diffuse Alveolar Hemorrhage Associated with Edoxaban Therapy","volume":"2016","author":"Nitta","year":"2016","journal-title":"Case Rep. Crit. Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"k2505","DOI":"10.1136\/bmj.k2505","article-title":"Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: Cohort study in primary care","volume":"362","author":"Vinogradova","year":"2018","journal-title":"BMJ"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.amjcard.2020.02.028","article-title":"Comparing Major Bleeding Risk in Outpatients With Atrial Fibrillation or Flutter by Oral Anticoagulant Type (from the National Cardiovascular Disease Registry\u2019s Practice Innovation and Clinical Excellence Registry)","volume":"125","author":"Wong","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e13071","DOI":"10.14814\/phy2.13071","article-title":"Anticoagulation increases alveolar hemorrhage in mice infected with influenza A","volume":"4","author":"Tatsumi","year":"2016","journal-title":"Physiol. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2007.11.035","article-title":"Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis","volume":"51","author":"Hurtado","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ahj.2006.06.024","article-title":"Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials","volume":"152","author":"Flaker","year":"2006","journal-title":"Am. Heart J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.thromres.2013.04.033","article-title":"Major bleeding risk in anticoagulated patients receiving concomitant antiplatelet therapy: A prospective study","volume":"131","author":"Rodondi","year":"2013","journal-title":"Thromb. Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Chen, P.C., Lip, G.Y., Yeh, G., Lin, H.J., and Chien, K.L. (2015). Risk of bleeding and stroke with oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation in Taiwan: A nationwide cohort study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0125257"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11239-019-01999-3","article-title":"Direct oral anticoagulant plus antiplatelet therapy: Prescribing practices and bleeding outcomes","volume":"49","author":"Tinkham","year":"2020","journal-title":"J. Thromb. Thrombol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1183\/09031936.00075309","article-title":"Diffuse alveolar haemorrhage: Factors associated with in-hospital and long-term mortality","volume":"35","author":"Parrot","year":"2010","journal-title":"Eur. Respir. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jcrc.2009.04.009","article-title":"Severe respiratory failure due to diffuse alveolar hemorrhage: Clinical characteristics and outcome of intensive care","volume":"25","author":"Rabe","year":"2010","journal-title":"J. Crit. Care."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1164\/rccm.200208-792OC","article-title":"Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients","volume":"166","author":"Afessa","year":"2002","journal-title":"Am. J. Respir Crit. Care Med."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/10\/1094\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:12:23Z","timestamp":1760166743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/10\/1094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,13]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["medicina57101094"],"URL":"https:\/\/doi.org\/10.3390\/medicina57101094","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,13]]}}}